Cryo-Cell International (CCEL) Price & Analysis

Compare

53 Followers

CCEL Stock Chart & Stats

$4.09

-$0.37(-4.74%)

At close: Jan 08 4:00 PM EST

$4.09

-$0.37(-4.74%)

Day’s Range― - ―

52-Week Range$3.10 - $7.91

Previous CloseN/A

Volume3.40K

Average Volume (3M)4.07K

Market Cap

$27.39M

Enterprise Value$30.03M

Total Cash (Recent Filing)$3.22M

Total Debt (Recent Filing)$4.21M

Price to Earnings (P/E)―

Beta0.12

Next Earnings

Apr 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield11.14%

Share Statistics

EPS (TTM)-0.46

Shares Outstanding8,055,150

10 Day Avg. Volume4,683

30 Day Avg. Volume4,066

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)-1.73

Price to Sales (P/S)1.02

P/FCF Ratio6.12

Enterprise Value/Market Cap1.10

Enterprise Value/Revenue0.95

Enterprise Value/Gross Profit1.23

Enterprise Value/Ebitda5.84

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.42

Revenue Forecast (FY)$29.90M

Bulls Say, Bears Say

Bulls Say

Core Business ResilienceCore operations in processing and storing stem cells remain strong, indicating sustained customer demand for preservation services and solid market positioning.

Gross Margin StrengthConsistently high gross margins in the core business provide flexibility to absorb cost pressures and fund strategic initiatives without immediate dilution of shareholder value.

Recurring RevenueHigh-margin recurring revenue from stem-cell processing and storage supports steady cash flow and improves revenue visibility, reducing dependence on one-time transactions.

Bears Say

Dividend Suspension And Ratings ImpactSuspension of the dividend and analyst downgrades to Hold signal weakening fundamentals and may dampen investor confidence and stock demand.

Legal And Arbitration RiskArbitration and a countersuit create substantial legal uncertainty, with potential damages exceeding $100 million and the prospect of significant litigation costs.

Revenue And New Business DeclineDeclines in new business processed have driven revenue decreases, undermining top-line growth and challenging efforts to restore sales momentum.

Cryo-Cell International News

Cryo-Cell International Halts Q4 2025 Dividend Declaration

Cryo-Cell International ( ($CCEL) ) has shared an update. Cryo-Cell International announced that it will not declare a...

4M ago

CCEL

Cryo-Cell International Amends Credit Agreement with Susser Bank

Cryo-Cell International ( ($CCEL) ) has shared an update. Cryo-Cell International, Inc. announced a Fifth Amendment to its...

4M ago

CCEL

Cryo-Cell downgraded to Hold from Buy at Maxim

Maxim analyst Allen Klee downgraded Cryo-Cell (CCEL) to Hold from Buy. Published first on TheFly – the ultimate...

4M ago

CCEL

Cryo-Cell Schedules 2025 Annual Stockholders Meeting

Cryo-Cell International ( ($CCEL) ) has provided an announcement. Cryo-Cell International has scheduled its 2025 Annual Meeting of...

6M ago

CCEL

Cryo-Cell will not declare dividend in Q3

Cryo-Cell (CCEL) announced that the company will not declare a quarterly cash dividend for the third quarter of...

7M ago

CCEL

Cryo-Cell reports Q2 EPS 4c vs. 8c last year.

Reports Q2 revenue $7.9M vs. $8.0M last year. Published first on TheFly – the ultimate source for real-time,...

8M ago

CCEL

Cryo-Cell Faces License Termination by Duke University

Cryo-Cell International ( ($CCEL) ) has issued an update. Cryo-Cell International, Inc. has received a notice of termination...

9M ago

CCEL

Cryo-Cell International Declares Reduced Quarterly Dividend

An announcement from Cryo-Cell International ( ($CCEL) ) is now available. On May 7, 2025, Cryo-Cell International‘s Board...

10M ago

CCEL

Cryo-Cell International: Strong Financial Performance and Strategic Positioning with Potential Upside

In a report released yesterday, Allen Klee from Maxim Group reiterated a Buy rating on Cryo-Cell International (CCEL...

11M ago

CCEL

Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz

The major averages were fractionally higher near noon, adding slightly to yesterday’s gains as investors reacted to fresh...

11M ago

Cryo-Cell reports Q1 EPS 3c vs. 7c last year

Reports Q1 revenue $7.97M vs. $7.85M last year. The company said, “The revenues for the first quarter of...

11M ago

CCEL

Cryo-Cell price target lowered to $8.50 from $9 at Maxim

Maxim lowered the firm’s price target on Cryo-Cell (CCEL) to $8.50 from $9 and keeps a Buy rating...

12M ago

CCEL

Cryo-Cell reports FY24 EPS 5c vs ($1.14) last year

Reports FY24 revenue $32M vs $31.3M last year. David Portnoy, Cryo-Cell’s (CCEL) Chairman of the Board and Co-CEO...

1y ago

CCEL

CRYO-CELL International, Inc. trading resumes

09:40 EDT CRYO-CELL (CCEL) International, Inc. trading resumes Published first on TheFly – the ultimate source for real-time,...

1y ago

CCEL

CCEL FAQ

What was Cryo-Cell International Inc’s price range in the past 12 months?

Cryo-Cell International Inc lowest stock price was $3.10 and its highest was $7.91 in the past 12 months.

What is Cryo-Cell International Inc’s market cap?

Cryo-Cell International Inc’s market cap is $27.39M.

When is Cryo-Cell International Inc’s upcoming earnings report date?

Cryo-Cell International Inc’s upcoming earnings report date is Apr 21, 2026 which is in 50 days.

How were Cryo-Cell International Inc’s earnings last quarter?

Cryo-Cell International Inc released its earnings results on Feb 27, 2026. The company reported -$0.46 earnings per share for the quarter, missing the consensus estimate of -$0.09 by -$0.37.

Is Cryo-Cell International Inc overvalued?

According to Wall Street analysts Cryo-Cell International Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cryo-Cell International Inc pay dividends?

Cryo-Cell International Inc pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 11.14%. See more information on Cryo-Cell International Inc dividends here

What is Cryo-Cell International Inc’s EPS estimate?

Cryo-Cell International Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cryo-Cell International Inc have?

Cryo-Cell International Inc has 8,055,150 shares outstanding.

What happened to Cryo-Cell International Inc’s price movement after its last earnings report?

Cryo-Cell International Inc reported an EPS of -$0.46 in its last earnings report, missing expectations of -$0.09. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of Cryo-Cell International Inc?

Currently, no hedge funds are holding shares in CCEL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cryo-Cell International Inc

Cryo-Cell International (CCEL) is a leading biotechnology company specializing in the collection, processing, and storage of stem cells derived from umbilical cord blood and tissue. Founded in 1992, CCEL operates primarily in the regenerative medicine sector, offering services that cater to families looking to preserve their newborn's stem cells for potential future medical use. The company's core offerings include private and public cord blood banking, as well as tissue banking services, which are critical for various therapeutic applications and research.